More Women Bearing the Brunt of COVID Vaccine Reactions and Injury
Early reports to the Vaccine Adverse Event Reporting System (VAERS), a centralized federally operated vaccine reaction reporting system, after the messenger RNA (mRNA) COVID-19 shots were distributed under an Emergency Use Authorization (EUA in the United States revealed that women were reported to have experienced more severe allergic reactions to the COVID-19 shots than men. […]
U.S. to Spend Billions on New COVID Vaccines Despite Failure to Prevent Infection
The Biden administration announced earlier this month that the U.S. government will spend at least $5 billion on Project NextGen to rapidly develop “next-generation” SARS-CoV-2 vaccines and treatments despite evidence that current COVID vaccines do not prevent infection and transmission of the new coronavirus.1 Following a similar approach to “Operation Warp Speed” initiated by the […]
Birth Rates Plummet in Countries Most Heavily Vaccinated Against COVID-19
A team of European researchers have determined that birth rates in 19 European countries declined sharply toward the end of 2021 following peak COVID-19 vaccine uptake earlier that year in the spring. The research, compiled in August 2022, found that decreased birth rate patterns persisted all of the countries represented in the data, including Germany, […]
CDC Adds COVID Shots to Recommended Vaccine Schedules for Children and Adults
The U.S. Centers for Disease Control and Prevention (CDC) has updated recommended vaccine schedules for children, adolescents and adults to include the COVID-19 biologics. The move is consistent with recommendations made by the agency’s Advisory Committee on Vaccine Practices (ACIP) in October 2022.1 2 3 4 5 The update of the recommended vaccination schedules was […]
Government Buys 1.5 Million More Doses of Novavax’s COVID Vaccine
Biotechnology company Novavax announced that it has made a modification to an existing contract with the U.S. Department of Health and Human Services (HHS) and the Department of Defense (DoD) to provide up to 1.5 million more doses of its Nuvaxovid COVID-19 vaccine (also known as “NVX-CoV2373” and “Covovax”), in addition to the 3.2 million […]
The Impending U.S. ICD Vaccine Passport and Its Unconstitutionality
The CDC recently codified International Classification of Disease (ICD) codes for COVID-19 vaccine status. ICD codes are extensively used in medical records, medical insurance data and health research to classify precisely disease states as well as injuries from exogenous agents such as accidents, medication and medical device injuries, toxic chemicals, etc. Vaccination status is not […]
How Can We Trust Institutions That Lied?
Trust the Authorities, trust the Experts, and trust the Science, we were told. Public health messaging during the COVID-19 pandemic was only credible if it originated from government health authorities, the World Health Organization, and pharmaceutical companies, as well as scientists who parroted their lines with little critical thinking. In the name of ‘protecting’ the […]
FDA Approves U.S. Babies and Young Children to Get Omicron COVID Booster Shots
In early December 2022, the U.S. Food and Drug Administration (FDA) amended the Emergency Use Authorization (EUA) for the Pfizer/BioNTech and Moderna/NIAID mRNA COVID-19 shots to include administration of the Omicron COVID booster shots to children as young as six months old. The action allows everyone over the age of six months to get the […]
Group B Strep Vaccine for Pregnant Women on Fast Track for FDA Approval
Pfizer is conducting phase 2 trials for the development of a vaccine that will target pregnant women to prevent newborns from infection with Group B Streptococcal (GBS). The vaccine was granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration (FDA) in September and the agency has indicated it will fast track the product’s […]
Monoclonal Antibodies No Longer Effective Against New Strains of SARS-CoV-2
Monoclonal antibodies, which are synthetic versions of antibodies that are produced in a lab, appear to have lost effectiveness against COVID-19 disease as new variants of the virus emerge. Previously touted as the top-of-the-line outpatient treatment by public health officials and many clinicians, monoclonal antibodies have fallen out of favor as outpatient treatment for patients […]
